safety of glp 1 receptor agonists Efficacy and Glucagon-Like Peptide-1 on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis Potential Use of GLP-1 and
Description
Ethics Approval and Consent to Participate The animal study protocol was approved by the Laboratory Animal Ethical Committee of Shanxi Medical University
Outcomes Figure 1 shows the network of comparisons for the outcomes
The microbiota in adaptive immune homeostasis and disease
Comorbidities in recent-onset adult type 1 diabetes: a comparison of German cohorts
